Preserved bevacizumab (Avastin®) eye drops for application in multidose containers – an in-vitro characterisation

Preserved bevacizumab (Avastin®) eye drops for application in multidose containers – an in-vitro characterisation

Abstract Purpose Monoclonal antibodies have made an immense contribution to the treatment of various human diseases. We aimed at investigating an affordable treatment option for veterinary patients with corneal neovascularization by adding the preservative benzalkonium chloride (BAC) to bevacizumab...

Full description

Saved in:
Bibliographic Details
Main Authors: Ulrike Lessiak, Tania Brandstoetter, Barbara Nell, Klara Klein, Georg Mlynek, Lukas Wimmer, Lisa Scheiblecker, Alexander Tichy, Andrea Hoelbl-Kovacic
Format: Article
Language:English
Published: BMC 2025-03-01
Series:BMC Veterinary Research
Subjects:
Anti-VEGF
Protein aggregation
Cornea
Angiogenesis
Online Access:https://doi.org/10.1186/s12917-025-04592-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12917-025-04592-4

Similar Items